Skip to content
The Policy VaultThe Policy Vault

TyenneMedical Mutual

Giant Cell Arteritis (GCA)

Initial criteria

  • Patient has tried one systemic corticosteroid (e.g., prednisone); AND
  • Medication is prescribed by or in consultation with a rheumatologist; AND
  • Site of care medical necessity is met

Reauthorization criteria

  • Patient has been established on therapy for at least 6 months; AND
  • Patient experienced a beneficial clinical response from baseline assessed by objective measures OR patient experienced an improvement in at least one symptom compared with baseline

Approval duration

initial: 6 months; reauth: 1 year